glp-1 and hrt The Case for Combining GLP-1s: A New Framework for Menopausal Healthspan GLP-1s and Hormone Therapy: A
Description
GLP-1 can disrupt your gut microbiome leading to diarrhea, consitpation, bloating, and abdominal pain
2020;36:e3223
GLP-1R agonists cannot be currently recommended as targeted approaches for MASH but should be administered for their indications (T2D, obesity)
Knowing your plans rules upfront saves weeks of frustration and prevents treatment gaps
Big changes continue to shake up the world of weight-management medications
Comparing weight loss outcomes: tirzepatide versus retatrutide The data tells a clear story
